From small molecules to sequences and everything in between, the rapid expansion of therapeutic modalities is redefining what informatics must deliver. At the same time, advances in AI are dissolving traditional silos, connecting chemistry with safety pharmacology, and enabling early insights into clinical relevance and potential efficacy long before a compound ever reaches the clinic.
At AI in Drug Discovery, Certara is joining the conversation on what it truly takes to keep pace with this transformation.
